| CAS No. | 181695-72-7 |
|---|---|
| MDL No. | MFCD00950568 |
| MF | C16H14N2O3S |
| MW | 314.40 |
| InChI Key | LNPDTQAFDNKSHK-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 250 mg | 99+% | $8 | In Stock | |
| 1 g | 99+% | $13 | In Stock | |
| 5 g | 98% | $47 | In Stock | |
| 25 g | 98% | $211 | In Stock | |
| 100 g | 99+% | $635 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Valdecoxib is an isoxazole substituted at positions 3, 4, and 5 with phenyl, p-sulfamoylphenyl, and methyl groups, respectively. It is a selective cyclooxygenase-2 inhibitor and a nonsteroidal anti-inflammatory drug (NSAID) used for arthritis treatment from 2001 to 2005. It was withdrawn due to concerns about increased risk of heart attack and stroke. It functions as a non-narcotic analgesic, antirheumatic, antipyretic, and is a member of isoxazoles and sulfonamides.
| CAS No. | 181695-72-7 |
|---|---|
| Product Name | Valdecoxib |
